These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 6417849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hemophilic dog model for evaluating therapeutic effectiveness of plasma protein fractions.
    Kingdon HS, Hassell TM.
    Blood; 1981 Nov; 58(5):868-72. PubMed ID: 6794675
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prothrombin complex concentrates for clinical use.
    Chandra S, Brummelhuis HG.
    Vox Sang; 1981 Nov; 41(5-6):257-73. PubMed ID: 6798760
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors.
    Abildgaard CF, Britton M, Harrison J.
    J Pediatr; 1976 Feb; 88(2):200-5. PubMed ID: 1249680
    [Abstract] [Full Text] [Related]

  • 11. Kinetic analysis of bovine factor VIII in the hemophilic dog.
    Gentry PA, Kirby EP, Gentry RD.
    Thromb Haemost; 1981 Aug 28; 46(2):485-8. PubMed ID: 6795739
    [Abstract] [Full Text] [Related]

  • 12. Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.
    Brinkhous KM, Sandberg H, Garris JB, Mattsson C, Palm M, Griggs T, Read MS.
    Proc Natl Acad Sci U S A; 1985 Dec 28; 82(24):8752-6. PubMed ID: 3936044
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ultrasonic purification of Bridge anticoagulant neutralizing agent (BANA) and a study on its effect on factor VIII inhibitor.
    Nour-Eldin F.
    Transfusion; 1979 Dec 28; 19(1):63-7. PubMed ID: 432913
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia.
    Thornburg CD, Pipe SW.
    Haemophilia; 2006 Mar 28; 12(2):198-9. PubMed ID: 16476098
    [No Abstract] [Full Text] [Related]

  • 20. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM, Skinner SF, Kaneko JJ.
    Am J Vet Res; 1975 Apr 28; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.